[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$OCUL Catalyst Date - 2025-10-16 Drug - AXPAXLI (OTX-TKI) Treatment - wet age-related macular degeneration (wet AMD)"
X Link @Biopharma_Watch 2025-10-15T15:45Z 1118 followers, XXX engagements
"@JeremyFalmouth @BalaBioResearch its not worth the premium you have in $OCUL currently. And lol how will the debate end both products have the place in the market. Owning this after recent raise is nonsensical at least to me and I bought around $X this year out at $XXXXX they think too much of themselves"
X Link @biotechsanya2 2025-10-14T22:11Z XXX followers, XXX engagements
"Midcaps ($2-20B) - Oct XX Gainers Losers $CRML +26% $DGNX -XXX% $NVTS +26% $VIST -XXX% $FLNC +17% $WSO.B -XXX% $DBRG +16% $INOD -XXX% $OUST +14% $SKE -XXX% $LUNR +14% $GGAL -X% $ORLA +14% $RYN -XXX% $PII +14% $TKC -XXX% $ACI +12% $PAM -XXX% $PCT +12% $OCUL -XXX% $WULF +10% $BMNR -XXX% $DLO +10% $PONY -XXX% $MARA +10% $TGS -XXX% $POWI +10% $ZLAB -XXX% $UUUU +9.8% $RBRK -5.5%"
X Link @MarketCap_Live 2025-10-14T19:48Z XXX followers, XXX engagements
"$OCUL is very interesting at this valuation even if you think SOL-1 has a XX% POS. Imagine the amount of people with wet AMD who just ask their doctor: "give me whatever has the least IVI's but still works." Easily a multi billion dollar drug if approved"
X Link @BalaBioResearch 2025-10-12T03:25Z 1024 followers, 2074 engagements